New agents in acute myeloid leukemia and
โ
Farhad Ravandi; Hagop Kantarjian; Francis Giles; Jorge Cortes
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 136 KB
## Abstract Over the past several decades, improvements in chemotherapeutic agents and supportive care have resulted in significant progress in treating patients with acute myeloid leukemia (AML). More recently, advances in understanding the biology of AML have resulted in the identification of new